A detailed history of Spider Rock Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 78,296 shares of AMGN stock, worth $20.6 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
78,296
Previous 81,623 4.08%
Holding current value
$20.6 Million
Previous $25.5 Million 1.08%
% of portfolio
0.41%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $1.03 Million - $1.12 Million
-3,327 Reduced 4.08%
78,296 $25.2 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $3.09 Million - $3.76 Million
11,772 Added 16.85%
81,623 $25.5 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $18.8 Million - $22.7 Million
69,851 New
69,851 $19.9 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $365,430 - $408,297
-2,165 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$167.29 - $191.0 $362,182 - $413,515
2,165
2,165 $401,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.